InsidersTradesSigma
Total declarations
Company
▲ Purchases (1 ops.)
▼ Sales (4 ops.)
Browse the detailed record of transactions filed by Downing Philip A, Vice-Président Senior. Director active across 1 companies, notably Inotiv, Inc.. In total, 7 reports have been published. Total volume traded: €509k. The latest transaction was filed on 22 February 2022 — Acquisition. Regulator: SEC (Form 4). All data is free.
Declarations7 total
€42,3942,000 shares@ €21.19680.085% mcap8.3% of flow
Common Shares
SEC:0001179110-22-001552:0·
Ideal exit: 19 Nov 2022 (T+270)
€116,5683,057 shares@ €38.13150.23% mcap50.0% of flow
Common Shares
SEC:0001179110-22-000454·
€116,5683,057 shares@ €38.13150.23% mcap22.9% of flow
Common Shares
SEC:0001179110-22-000454:0·
€116,5683,057 shares@ €38.13150.23% mcap50.0% of flow
Common Shares
SEC:0001179110-21-011278·
€116,5683,057 shares@ €38.13150.23% mcap22.9% of flow
Common Shares
SEC:0001179110-21-011278:0·
01,087 shares0
Common Shares
SEC:0001179110-21-009620·
01,087 shares0
Common Shares
SEC:0001179110-21-009620:0·
7 of 7 declarations
About Downing Philip A
Philip A. Downing is the Senior Vice President of Preclinical Services at Inotiv, Inc. He oversees the operations of the company's preclinical services, ensuring the quality and compliance of research. His expertise is essential for the development of new treatments.
